Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy.

Kidney international - 1 Feb 2008

Tang S C W, Leung J C K, Chan L Y Y, Eddy A A, Lai K N

Abstract excerpt

Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins have renoprotective effects. We studied the cellular mechanisms for this effect in adriamycin-treated mice receiving captopril, losartan, simvastatin, or their combinations. The mice developed albuminuria, ren...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Angiotensin II
Share to Angiotensin II Type 1 Receptor Blockers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokine CCL2

Share to Doxorubicin

Share to Glomerulosclerosis, Focal Segmental

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Pregnancy Proteins

Source

Identifiers

PMID: 18033243
DOI: 10.1038/sj.ki.5002674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-18033243-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy.PMID 18033243Read ↗

Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.Semantic proximity Read ↗

Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB.Semantic proximity Read ↗

Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.Semantic proximity Read ↗

The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy.Semantic proximity Read ↗

Development and Characterization of a Novel FVB-PrkdcR2140C Mouse Model for Adriamycin-Induced Nephropathy.Semantic proximity Read ↗

Protective effects of Rho kinase inhibitor fasudil on rats with chronic kidney disease.Semantic proximity Read ↗

Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.Semantic proximity Read ↗

Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.Semantic proximity Read ↗

Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes.Semantic proximity Read ↗

Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivoSemantic proximity Read ↗

Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome.Semantic proximity Read ↗

Assessing Mouse Kidney Parvovirus’ Ability to Confound Research by Examining its Effects on Renally Excreted Chemotherapeutics and its Impact on Pathologic Endpoints in the Adenine Model of Chronic Kidney DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.